Upstream Bio, Inc. (UPB)

Upstream Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	32.95	25.83	17.05
Short-Term Investments	187.71	83.98	-
Cash & Short-Term Investments	220.66	109.81	17.05
Cash Growth	1194.11%	544.01%	-
Accounts Receivable	0.61	0.1	0.41
Other Receivables	0.49	0.14	-
Receivables	1.09	0.24	0.41
Prepaid Expenses	0.06	0.12	0.09
Other Current Assets	5.46	6.83	0.75
Total Current Assets	227.27	117	18.31
Property, Plant & Equipment	2.49	0.2	0.16
Other Long-Term Assets	0.19	-	0.01
Total Assets	232.7	117.2	18.48
Accounts Payable	4.9	1.99	0.71
Accrued Expenses	4.51	4.48	4.06
Current Portion of Leases	0.68	0.05	0.09
Total Current Liabilities	10.87	6.52	4.86
Long-Term Leases	1.26	-	0.01
Other Long-Term Liabilities	-	2.87	6.95
Total Liabilities	12.14	9.39	11.81
Common Stock	0	0	0
Additional Paid-In Capital	8.87	4.82	1.28
Retained Earnings	-169.54	-127.97	-107.44
Comprehensive Income & Other	0.35	0.02	-
Total Common Equity	-160.31	-123.13	-106.16
Shareholders' Equity	220.56	107.81	6.67
Total Liabilities & Equity	232.7	117.2	18.48
Total Debt	1.94	0.05	0.09
Net Cash (Debt)	218.72	109.77	16.96
Net Cash Growth	1189.84%	547.31%	-
Net Cash Per Share	76.37	38.98	6.06
Filing Date Shares Outstanding	53.6	2.85	2.8
Total Common Shares Outstanding	3.03	2.85	2.8
Working Capital	216.4	110.48	13.45
Book Value Per Share	-52.99	-43.16	-37.91
Tangible Book Value	-160.31	-123.13	-106.16
Tangible Book Value Per Share	-52.99	-43.16	-37.91
Machinery	0.3	0.2	0.02
Construction In Progress	0.32	-	0.04
Leasehold Improvements	0.06	0.03	0.02

Source: S&P Capital IQ. Standard template. Financial Sources.